
ENDRA Life Sciences Inc. – NASDAQ:NDRA
ENDRA Life Sciences stock price today
ENDRA Life Sciences stock price monthly change
ENDRA Life Sciences stock price quarterly change
ENDRA Life Sciences stock price yearly change
ENDRA Life Sciences key metrics
Market Cap | 2.87M |
Enterprise value | N/A |
P/E | -0.56 |
EV/Sales | N/A |
EV/EBITDA | 0.33 |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | -0.03 |
EPS | -1.23 |
Revenue | N/A |
EBITDA | -10.10M |
Income | -9.89M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeENDRA Life Sciences stock price history
ENDRA Life Sciences stock forecast
ENDRA Life Sciences financial statements
Jun 2023 | 0 | -2.55M | |
---|---|---|---|
Sep 2023 | 0 | -3.10M | |
Dec 2023 | 428.40K | -1.45M | -340.69% |
Mar 2024 | 0 | -2.77M |
Dec 2023 | 428.40K | -1.45M | -340.69% |
---|---|---|---|
Mar 2024 | 0 | -2.77M | |
Oct 2025 | 100K | -432.18K | -432.19% |
Dec 2025 | 500K | -432.18K | -86.44% |
Analysts Price target
Financials & Ratios estimates
Payout ratio | 0% |
---|
2019 | 0.02% |
---|---|
2020 | 0% |
2021 | 0% |
2022 | |
2023 |
Jun 2023 | 9244776 | 2.31M | 25.03% |
---|---|---|---|
Sep 2023 | 7602917 | 2.40M | 31.65% |
Dec 2023 | 6754146 | 1.09M | 16.21% |
Mar 2024 | 5060701 | 1.36M | 26.92% |
Jun 2023 | -2.26M | 0 | 4.73M |
---|---|---|---|
Sep 2023 | -2.59M | 0 | 1.11M |
Dec 2023 | -2.17M | 2.27K | 1.67M |
Mar 2024 | -2.14M | -23.79K | 468.90K |
ENDRA Life Sciences alternative data
Aug 2023 | 21 |
---|---|
Sep 2023 | 21 |
Oct 2023 | 21 |
Nov 2023 | 21 |
Dec 2023 | 21 |
Jan 2024 | 21 |
Feb 2024 | 21 |
Mar 2024 | 21 |
Apr 2024 | 21 |
May 2024 | 21 |
Jun 2024 | 21 |
Jul 2024 | 21 |
ENDRA Life Sciences other data
Period | Buy | Sel |
---|---|---|
Aug 2022 | 40000 | 0 |
Nov 2022 | 10000 | 0 |
Dec 2022 | 1500 | 0 |
May 2023 | 140000 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | THORNTON MICHAEL MILOS officer: Chief Te.. | Common Stock | 15,000 | $1.65 | $24,750 | ||
Purchase | DIGIANDOMENICO ANTHONY director | Common Stock | 83,333 | $1.2 | $100,000 | ||
Purchase | DIGIANDOMENICO ANTHONY director | Warrants | 41,667 | $1.4 | $58,334 | ||
Purchase | THORNTON MICHAEL MILOS officer: Chief Te.. | Common Stock | 1,500 | $3.4 | $5,100 | ||
Purchase | TOKMAN ALEXANDER Y director | Common Stock | 10,000 | $0.17 | $1,700 | ||
Purchase | THORNTON MICHAEL MILOS officer: Chief Te.. | Common Stock | 20,000 | $0.27 | $5,400 | ||
Purchase | TOKMAN ALEXANDER Y director | Common Stock | 20,000 | $0.26 | $5,200 | ||
Purchase | THORNTON MICHAEL MILOS officer: Chief Te.. | Common Stock | 25,000 | $0.21 | $5,250 | ||
Purchase | THORNTON MICHAEL MILOS officer: Chief Te.. | Common Stock | 25,000 | $0.22 | $5,500 | ||
Purchase | MICHELON FRANCOIS ROGER director, officer.. | Common Stock | 5,100 | $0.19 | $969 |
Patent |
---|
Grant Filling date: 24 Feb 2022 Issue date: 2 Aug 2022 |
Grant Filling date: 25 Mar 2022 Issue date: 19 Jul 2022 |
Grant Filling date: 25 Mar 2022 Issue date: 5 Jul 2022 |
Grant Filling date: 17 Dec 2021 Issue date: 28 Jun 2022 |
Grant Filling date: 12 Feb 2020 Issue date: 24 May 2022 |
Grant Filling date: 18 Oct 2021 Issue date: 26 Apr 2022 |
Grant Filling date: 7 Nov 2018 Issue date: 19 Apr 2022 |
Grant Filling date: 1 Oct 2019 Issue date: 8 Mar 2022 |
Application Filling date: 21 May 2021 Issue date: 2 Dec 2021 |
Grant Filling date: 21 May 2021 Issue date: 16 Nov 2021 |
Quarter | Transcript |
---|---|
Q1 2024 14 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 28 Mar 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 14 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 14 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Francois Michelon (1966) Chairman, Pres & Chief Executive Officer | $511,340 |
Mr. Michael Thornton (1968) Chief Technology Officer | $363,770 |
-
What's the price of ENDRA Life Sciences stock today?
One share of ENDRA Life Sciences stock can currently be purchased for approximately $4.55.
-
When is ENDRA Life Sciences's next earnings date?
Unfortunately, ENDRA Life Sciences's (NDRA) next earnings date is currently unknown.
-
Does ENDRA Life Sciences pay dividends?
No, ENDRA Life Sciences does not pay dividends.
-
How much money does ENDRA Life Sciences make?
ENDRA Life Sciences has a market capitalization of 2.87M.
-
What is ENDRA Life Sciences's stock symbol?
ENDRA Life Sciences Inc. is traded on the NASDAQ under the ticker symbol "NDRA".
-
What is ENDRA Life Sciences's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of ENDRA Life Sciences?
Shares of ENDRA Life Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are ENDRA Life Sciences's key executives?
ENDRA Life Sciences's management team includes the following people:
- Mr. Francois Michelon Chairman, Pres & Chief Executive Officer(age: 59, pay: $511,340)
- Mr. Michael Thornton Chief Technology Officer(age: 57, pay: $363,770)
-
How many employees does ENDRA Life Sciences have?
As Jul 2024, ENDRA Life Sciences employs 21 workers.
-
When ENDRA Life Sciences went public?
ENDRA Life Sciences Inc. is publicly traded company for more then 8 years since IPO on 30 Jun 2017.
-
What is ENDRA Life Sciences's official website?
The official website for ENDRA Life Sciences is endrainc.com.
-
Where are ENDRA Life Sciences's headquarters?
ENDRA Life Sciences is headquartered at 3600 Green Court, Ann Arbor, MI.
-
How can i contact ENDRA Life Sciences?
ENDRA Life Sciences's mailing address is 3600 Green Court, Ann Arbor, MI and company can be reached via phone at +7 343350468.
ENDRA Life Sciences company profile:

ENDRA Life Sciences Inc.
endrainc.comNASDAQ
21
Medical - Diagnostics & Research
Healthcare
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Ann Arbor, MI 48105-1570
CIK: 0001681682
ISIN: US29273B3024
CUSIP: 29273B104